NCC-MFS5-C1

$600$1,500

Description

Cell line name NCC-MFS5-C1
Accession CVCL_B5YX
Resource Identification Initiative To cite this cell line use: NCC-MFS5-C1 (RRID:CVCL_B5YX)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 91.7 hours (PubMed=35053323).
Omics: SNP array analysis.
Derived from site: In situ; Right elbow, hypodermis; UBERON=UBERON_0001461+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=35053323).
Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (PubMed=35053323).
Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=35053323).
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 60Y
Category Cancer cell line
STR profile

Source(s): PubMed=35053323

Markers:

Amelogenin X,Y
CSF1PO 11
D5S818 11
D7S820 11,12
D13S317 11
D16S539 9
D21S11 30,32
TH01 8,9
TPOX 8
vWA 15,18

Publications
PubMed=35053323; DOI=10.3390/cells11020207
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T., Sugaya J., Kobayashi E., Kojima N., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-MFS5-C1: a novel patient-derived cell line of myxofibrosarcoma.
Cells 11:207.1-207.13(2022)

Cross-references
Encyclopedic resources Wikidata; Q112129415

Additional information

User Category

Academia/non-profit organization, For-profit organization

Reviews

There are no reviews yet.

Be the first to review “NCC-MFS5-C1”

Your email address will not be published. Required fields are marked *

CAPTCHA